Ranibizumab in Myopic Choroidal Neovascularization: A Subgroup Analysis by Ethnicity, Age, and Ocular Characteristics in RADIANCE.

MLA

Holz, Frank G., et al. “Ranibizumab in Myopic Choroidal Neovascularization: A Subgroup Analysis by Ethnicity, Age, and Ocular Characteristics in RADIANCE.” Ophthalmologica. Journal International d’ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde, vol. 236, no. 1, 2016, pp. 19–28. EBSCOhost, https://doi.org/10.1159/000446027.

APA

Holz, F. G., Tufail, A., Leveziel, N., Lai, T. Y. Y., Lanzetta, P., Wong, T. Y., Yu, H. G., Chen, Y. X., Heinrichs, N., Pilz, S., & Ohno-Matsui, K. (2016). Ranibizumab in Myopic Choroidal Neovascularization: A Subgroup Analysis by Ethnicity, Age, and Ocular Characteristics in RADIANCE. Ophthalmologica. Journal International d’ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde, 236(1), 19–28. https://doi.org/10.1159/000446027

Chicago

Holz, Frank G, Adnan Tufail, Nicolas Leveziel, Timothy Y Y Lai, Paolo Lanzetta, Tien Y Wong, Hyeong Gon Yu, et al. 2016. “Ranibizumab in Myopic Choroidal Neovascularization: A Subgroup Analysis by Ethnicity, Age, and Ocular Characteristics in RADIANCE.” Ophthalmologica. Journal International d’ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde 236 (1): 19–28. doi:10.1159/000446027.